(BBWI) Bath & Body Works - Ratings and Ratios
Fragrance, Candles, Soap, Lotion, Sanitizer
BBWI EPS (Earnings per Share)
BBWI Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 45.4% |
| Value at Risk 5%th | 69.5% |
| Relative Tail Risk | -6.98% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.47 |
| Alpha | -46.79 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.748 |
| Beta | 1.450 |
| Beta Downside | 1.469 |
| Drawdowns 3y | |
|---|---|
| Max DD | 56.17% |
| Mean DD | 26.33% |
| Median DD | 27.00% |
Description: BBWI Bath & Body Works November 06, 2025
Bath & Body Works, Inc. (NYSE: BBWI) is a specialty retailer focused on home fragrance, personal care, and related products, offering items such as 3-wick candles, diffusers, hand soaps, lotions, and body creams under the Bath & Body Works, White Barn, and other brand names.
The company sells its merchandise through a network of over 1,800 retail stores and a growing e-commerce platform in the United States and Canada, while international expansion is pursued via franchise, licensing, and wholesale partnerships.
Key recent metrics: FY 2023 revenue was approximately $3.5 billion, with same-store sales (SSS) up 4.2% YoY and e-commerce sales accelerating to roughly 15% of total revenue, reflecting strong digital adoption. The sector is highly sensitive to consumer discretionary spending and inflation trends, making household disposable income and CPI movements critical drivers of BBWI’s top-line performance.
For a deeper, data-driven dive into BBWI’s valuation assumptions and scenario analysis, you may find the research tools on ValueRay useful.
BBWI Stock Overview
| Market Cap in USD | 4,724m |
| Sub-Industry | Other Specialty Retail |
| IPO / Inception | 1985-07-01 |
| Return 12m vs S&P 500 | -37.9% |
| Analyst Rating | 3.85 of 5 |
BBWI Dividends
| Dividend Yield | 4.55% |
| Yield on Cost 5y | 5.10% |
| Yield CAGR 5y | 34.70% |
| Payout Consistency | 83.0% |
| Payout Ratio | 23.3% |
BBWI Growth Ratios
| CAGR 3y | -15.21% |
| CAGR/Max DD Calmar Ratio | -0.27 |
| CAGR/Mean DD Pain Ratio | -0.58 |
| Current Volume | 6283.8k |
| Average Volume | 5682.1k |
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income (728.0m TTM) > 0 and > 6% of Revenue (6% = 442.2m TTM) |
| FCFTA 0.16 (>2.0%) and ΔFCFTA 2.40pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 5.47% (prev 2.29%; Δ 3.18pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.21 (>3.0%) and CFO 1.00b > Net Income 728.0m (YES >=105%, WARN >=100%) |
| Net Debt (4.63b) to EBITDA (1.56b) ratio: 2.97 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.31 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (211.6m) change vs 12m ago -5.11% (target <= -2.0% for YES) |
| Gross Margin 44.60% (prev 44.01%; Δ 0.59pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 151.0% (prev 149.2%; Δ 1.76pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 4.42 (EBITDA TTM 1.56b / Interest Expense TTM 292.0m) >= 6 (WARN >= 3) |
Altman Z'' 0.91
| (A) 0.08 = (Total Current Assets 1.71b - Total Current Liabilities 1.30b) / Total Assets 4.81b |
| (B) -0.36 = Retained Earnings (Balance) -1.72b / Total Assets 4.81b |
| (C) 0.26 = EBIT TTM 1.29b / Avg Total Assets 4.88b |
| (D) -0.24 = Book Value of Equity -1.53b / Total Liabilities 6.36b |
| Total Rating: 0.91 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 62.75
| 1. Piotroski 7.50pt = 2.50 |
| 2. FCF Yield 8.37% = 4.19 |
| 3. FCF Margin 10.62% = 2.66 |
| 4. Debt/Equity -3.23 = -2.50 |
| 5. Debt/Ebitda 2.97 = -1.73 |
| 6. ROIC - WACC (= 29.76)% = 12.50 |
| 7. RoE -47.48% = -2.50 |
| 8. Rev. Trend -11.00% = -0.82 |
| 9. EPS Trend -30.70% = -1.54 |
What is the price of BBWI shares?
Over the past week, the price has changed by -1.92%, over one month by -15.42%, over three months by -26.56% and over the past year by -28.21%.
Is Bath & Body Works a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BBWI is around 19.75 USD . This means that BBWI is currently overvalued and has a potential downside of -10.23%.
Is BBWI a buy, sell or hold?
- Strong Buy: 7
- Buy: 4
- Hold: 8
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the BBWI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 38 | 72.6% |
| Analysts Target Price | 38 | 72.6% |
| ValueRay Target Price | 21.5 | -2.2% |
BBWI Fundamental Data Overview November 11, 2025
P/E Trailing = 6.8593
P/E Forward = 6.7522
P/S = 0.6409
P/EG = 0.7168
Beta = 1.449
Revenue TTM = 7.37b USD
EBIT TTM = 1.29b USD
EBITDA TTM = 1.56b USD
Long Term Debt = 3.89b USD (from longTermDebt, last quarter)
Short Term Debt = 194.0m USD (from shortTermDebt, last quarter)
Debt = 4.99b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.63b USD (from netDebt column, last quarter)
Enterprise Value = 9.35b USD (4.72b + Debt 4.99b - CCE 364.0m)
Interest Coverage Ratio = 4.42 (Ebit TTM 1.29b / Interest Expense TTM 292.0m)
FCF Yield = 8.37% (FCF TTM 783.0m / Enterprise Value 9.35b)
FCF Margin = 10.62% (FCF TTM 783.0m / Revenue TTM 7.37b)
Net Margin = 9.88% (Net Income TTM 728.0m / Revenue TTM 7.37b)
Gross Margin = 44.60% ((Revenue TTM 7.37b - Cost of Revenue TTM 4.08b) / Revenue TTM)
Gross Margin QoQ = 41.32% (prev 45.37%)
Tobins Q-Ratio = 1.94 (Enterprise Value 9.35b / Total Assets 4.81b)
Interest Expense / Debt = 1.36% (Interest Expense 68.0m / Debt 4.99b)
Taxrate = 32.63% (31.0m / 95.0m)
NOPAT = 869.1m (EBIT 1.29b * (1 - 32.63%))
Current Ratio = 1.31 (Total Current Assets 1.71b / Total Current Liabilities 1.30b)
Debt / Equity = -3.23 (negative equity) (Debt 4.99b / totalStockholderEquity, last quarter -1.55b)
Debt / EBITDA = 2.97 (Net Debt 4.63b / EBITDA 1.56b)
Debt / FCF = 5.91 (Net Debt 4.63b / FCF TTM 783.0m)
Total Stockholder Equity = -1.53b (last 4 quarters mean from totalStockholderEquity)
RoA = 15.12% (Net Income 728.0m / Total Assets 4.81b)
RoE = -47.48% (negative equity) (Net Income TTM 728.0m / Total Stockholder Equity -1.53b)
RoCE = 54.78% (EBIT 1.29b / Capital Employed (Equity -1.53b + L.T.Debt 3.89b))
RoIC = 35.76% (NOPAT 869.1m / Invested Capital 2.43b)
WACC = 5.99% (E(4.72b)/V(9.72b) * Re(11.36%) + D(4.99b)/V(9.72b) * Rd(1.36%) * (1-Tc(0.33)))
Discount Rate = 11.36% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.66%
[DCF Debug] Terminal Value 65.36% ; FCFE base≈744.2m ; Y1≈683.3m ; Y5≈611.0m
Fair Price DCF = 32.62 (DCF Value 6.73b / Shares Outstanding 206.2m; 5y FCF grow -10.28% → 3.0% )
EPS Correlation: -30.70 | EPS CAGR: -74.59% | SUE: -4.0 | # QB: 0
Revenue Correlation: -11.00 | Revenue CAGR: -1.26% | SUE: -0.19 | # QB: 0
Additional Sources for BBWI Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle